ChemLifeIntel
CHEMICAL & LIFE SCIENCES INTELLIGENCE
Access
ChemLifeIntel/Companies/K.C. Pharmaceuticals, Inc

K.C. Pharmaceuticals, Inc

HIGH RISKHQ: — · Private · Founded —
LISTINGPrivateFOUNDED0
FOCUS THERAPY AREAS
Manufacturer
COMPANY INTELLIGENCE SNAPSHOTlive
0
Manufacturing Sites
1
Intelligence Briefs
1
Active Regulatory Actions
HQ Country
NO ACTIVE REGULATORY ACTIONSClean compliance footprint across 0 monitored sites · HQ
View regulatory detail

INTELLIGENCE

Showing 1 of 1 briefs on K.C. Pharmaceuticals, Inc
REGULATORY INTELLIGENCE·Recall

K.C. Pharmaceuticals Recalls 589,848 Artificial Tears Bottles Over Sterility Concerns, Impacting Major US Brands

K.C. Pharmaceuticals, Inc. has initiated a Class II recall for 589,848 bottles of Artificial Tears Sterile Lubricant Eye Drops due to a critical "Lack of Assurance of Sterility." This nationwide U.S. recall, affecting multiple major brands including Leader and Good Sense, demands immediate action from procurement and supply chain leaders. Businesses must assess their exposure to K.C. Pharmaceuticals, Inc. and expedite qualification of alternative ophthalmic product manufacturers to mitigate supply disruption and patient safety risks.

90-Day Activity
K.C. Pharmaceuticals,ARTIFICIAL TEARS
CMCatherine Morrow· Senior Regulatory Intelligence Analyst
2026-04-08 Recall